According to people familiar with the matter, Citigroup is leading the preparation of a $2.45 billion debt financing to support KKR Group's acquisition of medical device manufacturer Integer Holdings. People familiar with the matter, who asked not to be named, said that the financing included actual debt of 2.1 billion US dollars of seven-year term loans and 350 million US dollars of unused revolving credit lines. In addition to Citigroup, Barclays, UBS Group, and Jefferies Financial Group will also provide debt funding for this transaction. People familiar with the matter added that this debt may be sold to investors in the US leveraged loan market in September. The terms of the transaction are still being negotiated, and there is a possibility of changes. KKR representatives declined to comment, and Citigroup and Integer have yet to respond to requests for comment.

According to people familiar with the matter, Citigroup is leading the preparation of a $2.45 billion debt financing to support KKR Group's acquisition of medical device manufacturer Integer Holdings. People familiar with the matter, who asked not to be named, said that the financing included actual debt of 2.1 billion US dollars of seven-year term loans and 350 million US dollars of unused revolving credit lines. In addition to Citigroup, Barclays, UBS Group, and Jefferies Financial Group will also provide debt funding for this transaction. People familiar with the matter added that this debt may be sold to investors in the US leveraged loan market in September. The terms of the transaction are still being negotiated, and there is a possibility of changes. KKR representatives declined to comment, and Citigroup and Integer have yet to respond to requests for comment.